Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arcadia BiosciencesRKDA -18.59%43 Current Ratio is 3.79 as of Mar. 2026, which is 35% below its 10-year median of 5.87. GuruFocus rates RKDA with a GF Score™ of 43/100 and a GF Value™ of $2.84 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,988 Consumer Packaged Goods companies, Arcadia Biosciences ranks better than 82.85% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Arcadia Biosciences's current ratio for the quarter that ended in Mar. 2026 was 3.79.
Arcadia Biosciences has a current ratio of 3.79. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Arcadia Biosciences's Current Ratio or its related term are showing as below:
RKDA'
s Current Ratio Range Over the Past 10 Years
Min: 2.52 Med: 5.87 Max: 16.69
Current: 3.79
During the past 13 years, Arcadia Biosciences's highest Current Ratio was 16.69. The lowest was 2.52. And the median was 5.87.
RKDA's Current Ratio is ranked better than 82.85% of 1988
companies
in the Consumer Packaged Goods industry
Industry Median: 1.725
vs RKDA: 3.79
Arcadia Biosciences (NAS:RKDA) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Arcadia Biosciences Current Ratio Related Terms
Arcadia Biosciences Current Ratio Historical Data
* Premium members only.
The historical data trend for Arcadia Biosciences's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RKDA vs ORISF, ARRT, CIMG: Current Ratio Comparison
For the Packaged Foods subindustry, Arcadia Biosciences's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcadia Biosciences Current Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's Current Ratio distribution charts can be found below:
* The bar in red indicates where Arcadia Biosciences's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcadia Biosciences (RKDA) has a Current Ratio of 3.79 as of Mar. 2026. This is 35% below median its historical median of 5.87. Over the past decade, Arcadia Biosciences' Current Ratio has ranged from 2.52 to 16.69. According to the industry distribution chart, Arcadia Biosciences ranks #341 out of 1988 companies in the Consumer Packaged Goods industry, placing it in the top 17.2%.
Is Arcadia Biosciences' Current Ratio too high?
Arcadia Biosciences' current Current Ratio of 3.79 is 35% below median its 10-year median of 5.87. Over the past 10 years, this metric has ranged from a low of 2.52 to a high of 16.69. The Consumer Packaged Goods industry median Current Ratio is 1.73. Arcadia Biosciences' value of 3.79 is 119.7% above this industry median. Based on the distribution chart, Arcadia Biosciences ranks #341 out of 1988 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Arcadia Biosciences has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arcadia Biosciences' Current Ratio compare to ORISF and ARRT?
According to the Consumer Packaged Goods industry distribution chart, Arcadia Biosciences ranks #341 out of 1988 companies for Current Ratio. This places Arcadia Biosciences in the top 17% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.73. Arcadia Biosciences' value of 3.79 is 119.7% above this benchmark. Historically, Arcadia Biosciences' own Current Ratio has ranged from 2.52 to 16.69 over the past decade. While the company's 10-year median is 5.87 vs. the industry median of 1.73, Arcadia Biosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Consumer Packaged Goods company?
The median Current Ratio among Consumer Packaged Goods companies is 1.73, based on 1,988 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arcadia Biosciences's current Current Ratio of 3.79 is 119.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median Current Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arcadia Biosciences's current Current Ratio is 3.79, which is 35% below median its own 10-year median of 5.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcadia Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Arcadia Biosciences (RKDA) is currently considered Possible Value Trap. The stock's GF Value™ is $2.84, compared to a current price of $0.56 — trading 80.3% below its estimated fair value. The current Current Ratio is 3.79, which is 35% below median its 10-year median of 5.87 and 119.7% above the Consumer Packaged Goods industry median of 1.73. Arcadia Biosciences' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Arcadia Biosciences (RKDA), the current Current Ratio is 3.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arcadia Biosciences (RKDA) Overvalued in 2026?
Based on GuruFocus' analysis, Arcadia Biosciences stock appears to be undervalued.
The current stock price of $0.56 is trading 80.3% below its estimated GF Value™ of $2.84.
GuruFocus considers Arcadia Biosciences to be Possible Value Trap.
Key valuation signals for RKDA:
Current Ratio: 3.79 (35% below median its 10-year median of 5.87)
GF Value™: $2.84 vs. price of $0.56 (80.3% below fair value)
Industry Position: 119.7% above the Consumer Packaged Goods median (#341 of 1988)
No single metric tells the full story. See the RKDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
43GF Score
Get the complete analysis for RKDA
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RKDA has been successfully added to your 
